The IFM Therapeutics brand, founded in 2015 (United States), from 496 sister brands and 17477 competing brands. IFM Therapeutics is owned by BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York The sector of IFM Therapeutics is Drug Manufacturers.
Investment simulator :
Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY
(IFM Therapeutics)
over 5 years*
USD 59.90